Medicines and Civil Aviation Notices




NEW ZEALAND GAZETTE, No. 41

12 APRIL 2012

Product:
Apo-Pramipexole
Active Ingredient:
Pramipexole hydrochloride 1mg
Dosage Form:
Tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Ontario, Canada

Product:
Hospira™ Cefoxitin Sodium
Active Ingredient:
Cefoxitin sodium 1.051g equivalent to cefoxitin 1g
Dosage Form:
Powder for injection
New Zealand Sponsor:
Hospira NZ Limited
Manufacturer:
Hospira Healthcare India Pvt. Limited, Tamil Nadu, India

Product:
Incivo
Active Ingredient:
Telaprevir 375mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturer:
Janssen-Cilag SpA, Latina, Italy

Dated this 4th day of April 2012.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2183

Renewal of Provisional Consent to the Distribution of Medicines

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product:
Atenolol tablets, USP
Active Ingredient:
Atenolol 50mg
Dosage Form:
Tablet
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Note: This renewed consent is valid for six months from 27 May 2012.

Product:
Atenolol tablets, USP
Active Ingredient:
Atenolol 100mg
Dosage Form:
Tablet
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Note: This renewed consent is valid for six months from 27 May 2012.

Dated this 4th day of April 2012.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2185

Authorities and Other Agencies of State Notices

Civil Aviation Authority of New Zealand

Civil Aviation Act 1990

Civil Aviation Rule Part 71—Designation of Airspace

Pursuant to Civil Aviation Rule Part 71.9(d), the following amendment was designated with effect from 19 April 2012:

  • The following new low flying zones are established:
    • NZL 364 Waitotara, West Wanganui
    • NZL 365, Pauri, East Wanganui

A copy of this amendment is available for viewing at www.caa.govt.nz (NZ Air Navigation Register)



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2012, No 41





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines - Apo-Pramipexole, Hospira™ Cefoxitin Sodium, and Incivo (continued from previous page)

🏥 Health & Social Welfare
4 April 2012
Medicines, Apo-Pramipexole, Hospira Cefoxitin Sodium, Incivo, Apotex NZ Limited, Hospira NZ Limited, Janssen-Cilag (New Zealand) Limited
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

🏥 Renewal of Provisional Consent to the Distribution of Medicines - Atenolol Tablets

🏥 Health & Social Welfare
4 April 2012
Medicines, Atenolol, Mylan New Zealand Limited, Provisional Consent
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

🚂 Designation of Airspace - New Low Flying Zones

🚂 Transport & Communications
Civil Aviation, Airspace, Low Flying Zones, Waitotara, Pauri